AVEANNA HEALTHCARE HOLDINGS
AVAHNASDAQUS Equity
$582.71▲ $51.40 (+8.82%)
Simulated price1h—
24h▲ 8.8%
7d▲ 6152.3%
14d▲ 5882.6%
30d▲ 5932.2%
1y▲ 7948.5%
🏦Market Cap
$234.92B
Large Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
—
Otter Score
67
Fair
Trading Snapshot
- Day Range
- $580.58 – $589.76
- 52-Week Range
- —
- Volume
- $2.82B
- Avg Volume
- $3.38B
- Shares Outstanding
- —
- Next Earnings
- Oct 17, 2026
Fundamentals Snapshot
- Annual Revenue
- $33.56B
- Last Q Revenue
- $8.11B
- P/E Ratio
- —
- P/S Ratio
- —
- EPS (TTM)
- —
- Dividend Yield
- —
Why Investors Own AVAH
- ✓High-growth profile — revenue up -5.4% YoY with expanding US Equity exposure.
- ✓Healthy economics — 37% gross margin and 28% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
Revenue (TTM)
$33.56B▼ −1.3% YoY
Gross Margin (TTM)
37.2%▲ +2.0% YoY
Operating Income (TTM)
$8.86B▼ −1.3% YoY
Free Cash Flow (TTM)
$9.40B▼ −1.3% YoY
About AVEANNA HEALTHCARE HOLDINGS
A company profile for AVEANNA HEALTHCARE HOLDINGS isn’t available yet — check back soon.
🦦
Otter Score Breakdown
ⓘ💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
Overall Score
Fair
67/100
Analyst Price Target
ⓘAverage Target
$659.32
▲ +13.1% Upside
High Target$819.26
Low Target$591.90
Based on 13 analysts
Latest News & Updates
🚀
Bloomberg·2h ago
AVEANNA HEALTHCARE HOLDINGS tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
🛰️
CNBC·5h ago
Analysts lift AVAH price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
🌌
Reuters·1d ago
AVEANNA HEALTHCARE HOLDINGS announces new agreement to expand its footprint
The move broadens the company’s reach and could add incremental revenue over the next year.